The key pathogenic event in the adamantinomatous craniopharyngiomas (ACP) pathway corresponds to Wnt activation along with the alterations of the MEK/ERK pathway. This evidence concerns the gene MAP2K7 and Adamantinomatous Craniopharyngioma.